MENU

PYPD PolyPid Ltd Forecast, Technical & Fundamental Analysis

PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology... Show more

PYPD
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
View a ticker or compare two or three
PYPD
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

PYPD is expected to report earnings to fall 171.43% to 25 cents per share on November 11

PolyPid Ltd PYPD Stock Earnings Reports
Q3'26
Est.
$0.25
Q2'26
Beat
by $0.05
Q1'26
Beat
by $0.70
Q4'25
Missed
by $0.08
Q3'25
Missed
by $0.04
The last earnings report on August 12 showed earnings per share of -34 cents, beating the estimate of -40 cents. With 123.72K shares outstanding, the current market capitalization sits at 117.20M.
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
TMF29.700.34
+1.16%
Direxion Daily 20+ Year Treasury Bull 3X ETF (TMF)
SCD15.010.08
+0.54%
LMP Capital and Income Fund
BILT27.720.14
+0.49%
iShares Infrastructure Active ETF (BILT)
CPSR26.270.03
+0.10%
Calamos S&P 500 Structured Alt Protection ETF - March
SCA24.40-0.04
-0.16%
GraniteShares Autocallable SMCI ETF (SCA)

PYPD and Stocks

Correlation & Price change

A.I.dvisor tells us that PYPD and AMLX have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PYPD and AMLX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PYPD
1D Price
Change %
PYPD100%
+0.76%
AMLX - PYPD
29%
Poorly correlated
-0.40%
SYRE - PYPD
29%
Poorly correlated
+2.86%
LSTA - PYPD
28%
Poorly correlated
+6.44%
TSHA - PYPD
28%
Poorly correlated
+1.26%
INM - PYPD
28%
Poorly correlated
+10.42%
More
A.I. Advisor
published General Information

General Information

a clinical stage biopharmaceutical company focusing on the development, manufacture, and commercialization of administered therapies to improve surgical outcomes

Industry Biotechnology

Industry
N/A
Address
18 Hasivim Street
Phone
+972 747195700
Employees
75
Web
https://www.polypid.com
PolyPid (PYPD) stock Forecast, Price Targets and Analysts Predictions - Tickeron.com